Table 1.
BNT162 Vaccine Candidate (Product Code) |
SARS-CoV-2 Variant a | Encoded Antigen | Sequence Variant b |
---|---|---|---|
BNT162b1 | Wild type | SARS-CoV-2 RBD, a secreted variant | V5 |
BNT162b2 | Wild type | Full-length SARS-CoV-2 S protein bearing mutations preserving neutralization-sensitive sites | V8 and V9 c |
BNT162b3 | Wild type | SARS-CoV-2 RBD, a membrane-bound variant | V5TM |
a Wild type refers to the USA-WA1/2020 strain. b Sequence variant refers to the nucleotide sequence of the RNA component encoding the antigen. c Note that there were two variants of the BNT162b2 vaccine tested. The RNA component of the two sequence variants (V8 and V9) have different nucleotide sequences, but both encode the same antigen. Abbreviations: RBD = receptor binding domain; S protein = spike protein; V = variant.